PM360

AUGUST 9, 2022

One reason for this growth is an increasing demand for personalized healthcare technologies as patients look for advances in how healthcare is delivered following the pandemic. NovaXS is on a mission to simplify the medication self-administration process and improve remote healthcare adherence. billion in 2030 at a CAGR of 9.2%.

Prescription 105

Prescription Medical Patients Side effects 105

Impetus Digital

AUGUST 2, 2024

In theory, this will allow for highly tailored, personalized therapy plans with superior efficacy and minimal side effects. Manufacturing Optimization While the manufacturing industry lags behind others in terms of AI uptake, there is no shortage of potential ways to leverage this technology.

Pharma 92

Pharma Manufacturing Medicine Marketing 92

Contrarian Sales Techniques

FEBRUARY 26, 2023

It is noteworthy that Malaysia has a pharmaceutical manufacturing sector that almost exclusively produces generic drugs, with sales revenues amounting to only 1.5% For example, non-branded generics account for more than 40% of the total US pharmaceutical market in the United States and more than 50% in the United Kingdom.

Pharmaceutical 52

Pharmaceutical Medicine Government Manufacturing 52

Medico Reach

FEBRUARY 8, 2023

With the use of trailblazing digital platforms, cost-effective technologies, big data analytics, blockchain, and artificial intelligence (AI), the landscape is undergoing a massive transition. The global pharmaceutical manufacturing market stood at USD 405.52 billion in 2020 and will project growth of USD 4.18 from 2023 to 2030.

Pharma 52

Pharma Medicine Marketing Prospecting 52

PM360

AUGUST 26, 2024

Unlike the “un”targeted approaches that are often associated on the trial-and-error method, an expanded definition of precision medicine, with a smarter and more integrated tool set, will enable healthcare professionals (HCPs) to try the optimal therapeutic approach… the first time.

Medicine 52

Medicine Food and Drug Administration Government Insurance 52

European Pharmaceutical Review

FEBRUARY 20, 2025

However, in the long term, increased costs could be passed on to healthcare systems, insurers, and ultimately, patients. 4 Reshoring and diversification of pharmaceutical supply chains In response to potential tariffs, pharmaceutical manufacturers could consider shifting production closer to domestic markets to reduce exposure.

Pharmaceutical 20

Pharmaceutical Manufacturing Medicine Pharmaceutical manufacturing 20